Lexicon Pharmaceuticals
  • Home
  • Contact Us
  • Site Map
  • About Us
    • About Us Home
    • Management Team
    • Board of Directors
    • Development Team
    • Locations
    • Contact Us
    • History
  • Pipeline
    • Drug Pipeline Home
    • Our Goal
    • Therapeutic Areas
    • Drug Development Team
    • Clinical Trials
    • Publications
  • Discovery
    • Discovery Home
    • Discovery Process
    • Technology
    • Genome5000
    • Medicinal Chemistry
    • Patents
    • Academic Access
    • Technology Licensing
    • Scientific Publications
  • Alliances
    • Alliances Home
    • Current Alliances
    • Technology Licensing
  • Careers
    • Careers Home
    • Opportunities
    • Our Culture
    • Benefits
    • Community Involvement
    • The Woodlands
    • Princeton
    • Awards and Recognition
  • News
    • News Home
    • Media Inquiries
  • Investors
    • Investors Home
    • Media
    • Events
    • Stock Quote
    • SEC Filings
    • Annual Reports
    • Corporate Governance
    • Request Information
Lexicon Banner
  • Investors Home
  • Media
  • Events
  • Stock Quote
  • SEC Filings
  • Annual Reports
  • Corporate Governance
  • Request Information
Events

Lexicon to hold annual R&D Day on Thursday, April 8 in New York

 

Fourth Quarter & Full Year 2009 Conference Call and Webcast
Tuesday, 02/23/2010 11:00 am ET

 

LX4211 Phase 2a Results Conference Call and Webcast
Thursday, 01/28/2010 11:30 am ET

 
Lexicon presented positive Phase 2 results for LX1031 at GASTRO - November 25, 2009 - London, UK
 

LX1031 Phase 2 Results Conference Call Audio Link - November 13, 2009
 

 

Lexicon presented at the Morgan Stanley Global Healthcare Unplugged Conference - September 15, 2009 - New York, NY

 

Lexicon presented at Thomas Weisel Partners Healthcare Conference - September 9, 2009 - Boston, MA

 


  • About Us
  • Pipeline
  • Discovery
  • Alliances
  • Careers
  • News
  • Investors
  • Terms Of Use

Copyright © 2009, Lexicon Pharmaceuticals, Inc. All rights reserved.